Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C

OBJECTIVE: To explore the expected long-term health and economic outcomes of telaprevir (TVR) plus peginterferon alfa-2a and ribavirin (PR), a regimen that demonstrated substantially increased sustained virologic response (SVR) compared with PR alone in adults with chronic genotype 1 hepatitis C vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Brogan, Anita J., Talbird, Sandra E., Thompson, James R., Miller, Jeffrey D., Rubin, Jaime, Deniz, Baris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946047/
https://www.ncbi.nlm.nih.gov/pubmed/24603445
http://dx.doi.org/10.1371/journal.pone.0090295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946047/
https://www.ncbi.nlm.nih.gov/pubmed/24603445
http://dx.doi.org/10.1371/journal.pone.0090295

Ejemplares similares